Article 15 Aug 2022 Bio/Pharma IPRs: Will Institution Rates Rise In Response To USPTO Initiatives? United States IP
Article 15 Jul 2022 PTAB Updates: Director Vidal Grants Director Review, Sets Schedule And Authorizes Amicus Briefing United States IP
Article 11 Jul 2022 FDA Stays Juul Ban, Announces Plan To Implement New Policies United States Healthcare
Article 24 Jun 2022 PTAB Updates: USPTO Issues Update On Fintiv Practice And Provides Further Guidance On The Interim Director Review Process United States IP
Article 13 Jun 2022 USPTO Issues Updated Guidance On Use Of Applicant Admitted Prior Art In IPR Proceedings United States IP
Article 30 May 2022 PTAB Update: USPTO Issues Interim Process For PTAB Decision Internal Review And The Federal Circuit Issues An Opinion In Arthrex v. Smith & Nephew United States IP
Article 25 Apr 2022 The USPTO Issues Press Release Announcing Plans To Formalize The Director Review Process United States IP
Article 15 Dec 2021 ModernaTx, Inc. v. Arbutus Biopharma Corp.: Sublicense Not Enough To Show Standing United States IP
Article 25 Nov 2021 ALJ Cheney Finds Violation Of Section 337 In Certain Shingled Solar Modules (337-TA-1223) United States IP